Viewing Study NCT00670358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-07-05 @ 10:57 PM
Study NCT ID: NCT00670358
Status: COMPLETED
Last Update Posted: 2025-01-10
First Post: 2008-04-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II adult diffuse large cell lymphoma View
None noncontiguous stage II adult diffuse large cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None contiguous stage II grade 3 follicular lymphoma View
None noncontiguous stage II grade 3 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View